Market is experiencing significant transformations driven by evolving industrial demands, regulatory changes, and economic factors. This comprehensive research report delves deep into the market ...

Icosapent Ethyl is a synthetic derivate of the omega-3 fatty acid eicosapentaenoic acid (EPA), prescribed as an adjunct to diet to reduce hypertriglyceridemia in adults.

Austrian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Risk of Cardiovascular Events in Eligible Patients-- -- Effective 1 April 2025, Austrian ...